Epivincamine

CAS : 6835-99-0

Ref. 3D-GAA83599

Informations sur le produit

• Nom: Epivincamine
• Synonymes: (-)-cis-Epivincamine, 14-Epivincamine, 16-Epivincamine, 1H-Indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine, eburnamenine-14-carboxylic acid deriv., Eburnamenine-14-carboxylic acid, 14,15-dihydro-14-hydroxy-, methyl ester, (3alpha,14alpha,16alpha)-, Eburnamenine-14-carboxylic acid, 14,15-dihydro-14-hydroxy-, methyl ester, (3α,14α,16α)-, Methyl (3Alpha,14Alpha,16Alpha)-14-Hydroxy-14,15-Dihydroeburnamenine-14-Carboxylate, Methyl (3alpha,14alpha,16alpha)-14,15-dihydro-14-hydroxyeburnamenine-14-carboxylate
• CAS: 6835-99-0

Description

Epivincamine is an analog of the anticancer drug linezolid, which has been shown to have potent inhibitory effects on cancer cell growth. It works by blocking the activity of kinases, which are enzymes that play a key role in regulating cell growth and division. Epivincamine has been found to induce apoptosis (programmed cell death) in cancer cells and inhibit tumor growth. It has also been shown to inhibit the activity of protein kinases in Chinese hamster ovary cells and human urine, suggesting that it may be useful as a kinase inhibitor for cancer therapy. Overall, Epivincamine represents a promising new approach to the treatment of cancer and other diseases characterized by abnormal cell growth.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 354.4 g/mol
• Formule: C₂₁H₂₆N₂O₃
• Degré de pureté: Min. 95%